Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Kikuo Arakawa
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Devices
Procedures
Living Beings
Geographic Areas
Physiology
Sign-in to see full Profile
Network (preview)
67
Saku, Keijiro
61
Sasaki, Jun
54
Ideishi, Munehito
42
Sasaguri, M
29
Matsunaga, Akira
24
Zhang, Bo
22
Nii, Takanobu
22
Hiroki, Tadayuki
21
Shirai, Kazuyuki
20
Kumagai, Koichiro
19
Jimi, Shiro
17
Kinoshita, A
17
Tanaka, Hiroaki
17
Shindo, Munehiro
13
Urata, Hidenori
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Kikuo Arakawa (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Tanigawara Yusuke; Yoshihara Kazutaka; Kuramoto Kizuku; Arakawa Kikuo
Comparative pharmacodynamics of olmesartan and azelnidipine in patients with hypertension: a population pharmacokinetic/pharmacodynamic analysis.
Drug metabolism and pharmacokinetics 2009;24(4):376-88.
-
2006: Arakawa Kikuo
[Salt hypertension in chimpanzees]
Nippon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 5():316-22.
-
2006: Arakawa Kikuo
[Introduction: Seeing the forest as well as the tree]
Nippon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 5():1-2.
-
2005: Iwashita Mikio; Matsushita Yasuyuki; Sasaki Jun; Arakawa Kikuo; Kono Suminori;
Relation of serum total cholesterol and other factors to risk of cerebral infarction in Japanese men with hypercholesterolemia.
Circulation journal : official journal of the Japanese Circulation Society 2005;69(1):1-6.
-
2004: Iwashita Mikio; Matsushita Yasuyuki; Sasaki Jun; Arakawa Kikuo; Kono Suminori;
Relation of serum total cholesterol and other risk factors to risk of coronary events in middle-aged and elderly Japanese men with hypercholesterolemia: the Kyushu Lipid Intervention Study.
Circulation journal : official journal of the Japanese Circulation Society 2004;68(5):405-9.
-
2004: Arakawa Kikuo
[Development of combined drugs (ARB and diuretics)]
Nippon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 3():662-5.
-
2004: Arakawa Kikuo
[Organ protection by antihypertensive measures]
Nippon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 3():553-7.
-
2004: Washio Masakazu; Tokunaga Shoji; Yoshimasu Kouichi; Kodama Hiroko; Liu Ying; Sasazuki Shizuka; Tanaka Keitaro; Kono Suminori; Mohri Masahiro; Takeshita Akira; Arakawa Kikuo; Ideishi Munehito; Nii Takanobu; Shirai Kazuyuki; Arai Hidekazu; Doi Yoshitaka; Kawano Tomoki; Nakagaki Osamu; Takada Kazuyuki; Hiyamuta Koji; Koyanagi Samon
Role of prehypertension in the development of coronary atherosclerosis in Japan.
Journal of epidemiology / Japan Epidemiological Association 2004;14(2):57-62.
-
2003: Koga Takafumi; Urata Hidenori; Inoue Yukiko; Hoshino Takafumi; Okamoto Takehiro; Matsunaga Akira; Suzuki Misao; Miyazaki Junichi; Ideishi Munehito; Arakawa Kikuo; Saku Keijiro
Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy.
Hypertension research : official journal of the Japanese Society of Hypertension 2003;26(9):759-68.
-
2003: Kumagai Koichiro; Nakashima Hideko; Urata Hidenori; Gondo Naoki; Arakawa Kikuo; Saku Keijiro
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.
Journal of the American College of Cardiology 2003;41(12):2197-204.
-
2003: Sasaki Jun; Arakawa Kikuo; Iwashita Mikio; Matsushita Yasuyuki; Kono Suminori;
Reduction in serum total cholesterol and risks of coronary events and cerebral infarction in Japanese men: the Kyushu Lipid Intervention Study.
Circulation journal : official journal of the Japanese Circulation Society 2003;67(6):473-8.
-
2003: Hoshino Fumihiro; Urata Hidenori; Inoue Yukiko; Saito Yuri; Yahiro Eiji; Ideishi Munehito; Arakawa Kikuo; Saku Keijiro
Chymase inhibitor improves survival in hamsters with myocardial infarction.
Journal of cardiovascular pharmacology 2003;41 Suppl 1():S11-8.
-
2003: Yahiro Eiji; Ideishi Munehito; Wang Li Xing; Urata Hidenori; Kumagai Koichiro; Arakawa Kikuo; Saku Keijiro
Reperfusion-induced arrhythmias are suppressed by inhibition of the angiotensin II type 1 receptor.
Cardiology 2003;99(2):61-7.
-
2002: Uehara Yoshinari; Urata Hidenori; Ideishi Munehito; Arakawa Kikuo; Saku Keijiro
Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta.
Cardiovascular research 2002;55(4):870-6.
-
2002: Arakawa Kikuo
Mild physical exercise may activate the adenosine-dopamine system: a new natriuretic mechanism.
Current hypertension reports 2002;4(1):1-2.
-
2002: Yoshimasu Kouichi; Washio Masakazu; Tokunaga Shoji; Tanaka Keitaro; Liu Ying; Kodama Hiroko; Arai Hidekazu; Koyanagi Samon; Hiyamuta Koji; Doi Yoshitaka; Kawano Tomoki; Nakagaki Osamu; Takada Kazuyuki; Sasazuki Shizuka; Nii Takanobu; Shirai Kazuyuki; Ideishi Munehito; Arakawa Kikuo; Mohri Masahiro; Takeshita Akira
Relation between type A behavior pattern and the extent of coronary atherosclerosis in Japanese women.
International journal of behavioral medicine 2002;9(2):77-93.
-
2001: Liu Y; Tanaka H; Sasazuki S; Yoshimasu K; Kodama H; Washio M; Tanaka K; Tokunaga S; Kono S; Arai H; Koyanagi S; Hiyamuta K; Doi Y; Kawano T; Nakagaki O; Takada K; Nii T; Shirai K; Ideishi M; Arakawa K; Mohri M; Takeshita A
Alcohol consumption and severity of angiographically determined coronary artery disease in Japanese men and women.
Atherosclerosis 2001;156(1):177-83.
-
2001: Wang L X; Ideishi M; Yahiro E; Urata H; Arakawa K; Saku K
Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury.
Hypertension research : official journal of the Japanese Society of Hypertension 2001;24(2):179-87.
-
2001: Tanaka K; Kodama H; Sasazuki S; Yoshimasu K; Liu Y; Washio M; Tokunaga S; Kono S; Arai H; Koyanagi S; Hiyamuta K; Doi Y; Kawano T; Nakagaki O; Takada K; Nii T; Shirai K; Ideishi M; Arakawa K; Mohri M; Takeshita A
Obesity, body fat distribution and coronary atherosclerosis among Japanese men and women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2001;25(2):191-7.
-
2001: Takezako T; Noda K; Tsuji E; Koga M; Sasaguri M; Arakawa K
Adenosine activates aromatic L-amino acid decarboxylase activity in the kidney and increases dopamine.
Journal of the American Society of Nephrology : JASN 2001;12(1):29-36.
-
2000: Sasaguri M; Noda K; Matsumoto T; Shirai K; Tsuji E; Tsuji Y; Arakawa K
A case of hyperreninemic hypertension after extracorporeal shock-wave lithotripsy.
Hypertension research : official journal of the Japanese Society of Hypertension 2000;23(6):709-12.
-
2000: Arakawa K; Urata H
Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis.
Hypertension 2000;36(4):638-41.
-
2000: Arakawa K
[Prescription of exercise for hypertension]
Nippon rinsho. Japanese journal of clinical medicine 2000;58 Suppl():366-71.
-
2000: Maeda H; Sasaguri M; Sakai T; Kinoshita A; Koga M; Noda K; Tsuji E; Ideishi M; Arakawa K
Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats.
Hypertension research : official journal of the Japanese Society of Hypertension 2000;23(5):511-9.
-
2000: Sasazuki S; Kodama H; Yoshimasu K; Liu Y; Washio M; Tanaka K; Tokunaga S; Kono S; Arai H; Doi Y; Kawano T; Nakagaki O; Takada K; Koyanagi S; Hiyamuta K; Nii T; Shirai K; Ideishi M; Arakawa K; Mohri M; Takeshita A
Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women.
Annals of epidemiology 2000;10(6):401-8.
-
2000: Yoshimasu K; Liu Y; Kodama H; Sasazuki S; Washio M; Tanaka K; Tokunaga S; Kono S; Arai H; Koyanagi S; Hiyamuta K; Doi Y; Kawano T; Nakagaki O; Takada K; Nii T; Shirai K; Ideishi M; Arakawa K; Mohri M; Takeshita A
Job strain, Type A behavior pattern, and the prevalence of coronary atherosclerosis in Japanese working men.
Journal of psychosomatic research 2000;49(1):77-83.
-
2000: Sasaguri M; Noda K; Tashiro E; Notomo J; Tsuji E; Koga M; Arakawa K
The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients.
Hypertension research : official journal of the Japanese Society of Hypertension 2000;23(4):317-22.
-
2000: Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
Atherosclerosis 2000;150(2):343-55.
-
2000: Nakashima H; Kumagai K; Urata H; Gondo N; Ideishi M; Arakawa K
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation.
Circulation 2000;101(22):2612-7.
-
2000: Ideishi M; Yahiro E; Arakawa K
[Development and trends in antihypertensive drugs--introduction]
Nippon rinsho. Japanese journal of clinical medicine 2000;58 Suppl 2():257-62.
-
2000: Sasaguri M; Arakawa K
[Candesartan, angiotensin II receptor antagonist]
Nippon rinsho. Japanese journal of clinical medicine 2000;58 Suppl 2():144-8.
-
2000: Nishikawa H; Ideishi M; Nishimura T; Kawamura A; Kamochi H; Tahara H; Tsuchiya Y; Shirai K; Okabe M; Arakawa K
Deep venous thrombosis and pulmonary thromboembolism associated with a huge uterine myoma--a case report.
Angiology 2000;51(2):161-6.
-
2000: Noda K; Arakawa K
[Brief review: molecular biology of vasoactive substance and signal transduction]
Nippon rinsho. Japanese journal of clinical medicine 2000;58 Suppl 1():61-5.
-
2000: Tsuji E; Arakawa K
[Hemodynamics]
Nippon rinsho. Japanese journal of clinical medicine 2000;58 Suppl 1():7-12.
-
2000: Uehara Y; Urata H; Sasaguri M; Ideishi M; Sakata N; Tashiro T; Kimura M; Arakawa K
Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia.
Hypertension 2000;35(1 Pt 1):55-60.
-
2000: Huang W; Sasaki J; Matsunaga A; Han H; Li W; Koga T; Kugi M; Ando S; Arakawa K
A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(1):210-6.
-
2000: Ihara M; Urata H; Shirai K; Ideishi M; Hoshino F; Suzumiya J; Kikuchi M; Arakawa K
High cardiac angiotensin-II-forming activity in infarcted and non-infarcted human myocardium.
Cardiology 2000;94(4):247-53.
-
2000: Matsumoto N; Ideishi M; Sasaguri M; Nii T; Nakashima Y; Arakawa K
Effects of a slow-release nifedipine on 24-hour ambulatory blood pressure and ischemic changes on 24-hour ambulatory electrocardiogram in patients with severe coronary artery disease.
Cardiology 2000;94(1):36-43.
-
1999: Saku K; Zhang B; Shirai K; Jimi S; Yoshinaga K; Arakawa K
Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease.
Journal of the American College of Cardiology 1999;34(5):1443-51.
-
1999: Matsuda H; Hayashi K; Arakawa K; Naitoh M; Kubota E; Honda M; Matsumoto A; Suzuki H; Yamamoto T; Kajiya F; Saruta T
Zonal heterogeneity in action of angiotensin-converting enzyme inhibitor on renal microcirculation: role of intrarenal bradykinin.
Journal of the American Society of Nephrology : JASN 1999;10(11):2272-82.
-
1999: Arakawa K
Let us return to a more natural lifestyle.
Current hypertension reports 1999;1(5):363-4.
-
1999: Sasaguri M; Noda K; Tsuji E; Koga M; Kinoshita A; Ideishi M; Ogata S; Arakawa K
Structure of a kallikrein-like enzyme and its tissue localization in the dog.
Immunopharmacology 1999;44(1-2):15-9.
-
1999: Saruta T; Arakawa K; Iimura O; Abe K; Matsuoka H; Nakano T; Nakagawa M; Ogihara T; Kajiyama G; Hiwada K; Fujishima M; Nakajima M
Difference in the incidence of cough induced by angiotensin converting enzyme inhibitors: a comparative study using imidapril hydrochloride and enalapril maleate.
Hypertension research : official journal of the Japanese Society of Hypertension 1999;22(3):197-202.
-
1999: Takezako T; Saku K; Zhang B; Shirai K; Arakawa K
Insulin resistance and angiographical characteristics of coronary atherosclerosis.
Japanese circulation journal 1999;63(9):666-73.
-
1999: Saku K; Zhang B; Liu R; Shirai K; Arakawa K
Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
Japanese circulation journal 1999;63(9):659-65.
-
1999: Liu K; Ou J; Saku K; Jimi S; Via D P; Sparrow J T; Zhang B; Pownall H J; Smith L C; Arakawa K
Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apo E peptide in a human CETP-stably transfected CHO cell line.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(9):2207-13.
-
1999: Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S
[A comparative long-term trial of sodium cerivastatin, a new HMG-CoA reductase inhibitor, in patients presenting with primary hypercholesterolemia]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1999;20 Suppl 3():393s-398s.
-
1999: Liao Y L; Saku K; Ou J; Jimi S; Zhang B; Shirai K; Arakawa K
A missense mutation of the nitric oxide synthase (eNOS) gene (Glu298Asp) in five patients with coronary artery disease--case reports.
Angiology 1999;50(8):671-6.
-
1999: Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
Kidney international 1999;56(2):421-7.
-
1999: Okabe M; Fukuda K; Arakawa K
Postmortem evaluation of morphologic changes in the infarcted myocardium that predict ventricular septal rupture in acute anteroseptal infarction.
Japanese circulation journal 1999;63(6):485-9.
-
1999: Ou J; Saku K; Jimi S; Liao Y L; Ohta T; Zhang B; Arakawa K
Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
Japanese circulation journal 1999;63(6):471-7.
-
1999: Ihara M; Urata H; Kinoshita A; Suzumiya J; Sasaguri M; Kikuchi M; Ideishi M; Arakawa K
Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta.
Hypertension 1999;33(6):1399-405.
-
1999: Han H; Sasaki J; Matsunaga A; Hakamata H; Huang W; Ageta M; Taguchi T; Koga T; Kugi M; Horiuchi S; Arakawa K
A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(6):1447-55.
-
1999: Noda K; Arakawa K
[Pathophysiology of the renin-angiotensin system]
Nippon rinsho. Japanese journal of clinical medicine 1999;57(5):1009-14.
-
1999: Saku K; von Eckardstein A; Zhang B; Liu R; Jimi S; Ou J; Ohta T; Assmann G; Arakawa K
In vivo kinetics of human apolipoprotein A-I variants in rabbits.
European journal of clinical investigation 1999;29(3):196-203.
-
1999: Takezako T; Saku K; Zhang B; Ou J; Bai H; Imai K; Jimi S; Shirai K; Arakawa K
Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris.
American journal of hypertension 1999;12(3):291-7.
-
1999: Jimi S; Uesugi N; Saku K; Itabe H; Zhang B; Arakawa K; Takebayashi S
Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):794-801.
-
1999: Matsunaga A; Sasaki J; Han H; Huang W; Kugi M; Koga T; Ichiki S; Shinkawa T; Arakawa K
Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(2):348-55.
-
1999: Saku K; Zhang B; Ohta T; Arakawa K
Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis.
Journal of the American College of Cardiology 1999;33(2):436-43.
-
1999: Saku K; Zhang B; Ohta T; Shirai K; Tsuchiya Y; Arakawa K
Levels of soluble cell adhesion molecules in patients with angiographically defined coronary atherosclerosis.
Japanese circulation journal 1999;63(1):19-24.
-
1999: Annoura M; Ogawa M; Kumagai K; Zhang B; Saku K; Arakawa K
Cholesterol paradox in patients with paroxysmal atrial fibrillation.
Cardiology 1999;92(1):21-7.
-
1998: Tsuchiya Y; Nii T; Shirai K; Saku K; Arakawa K
Parasympathetic tone affects electrocardiographic preconditioning during right coronary angioplasty.
Cardiology 1998;90(2):122-6.
-
1998: Akasu M; Urata H; Kinoshita A; Sasaguri M; Ideishi M; Arakawa K
Differences in tissue angiotensin II-forming pathways by species and organs in vitro.
Hypertension 1998;32(3):514-20.
-
1998: Tsuji E; Tsuji Y; Sasaguri M; Arakawa K
Function and expression of a novel rat salt-tolerant protein: evidence of a role in cellular sodium metabolism.
Journal of the American Society of Nephrology : JASN 1998;9(9):1574-80.
-
1998: Uehara Y; Sasaguri M; Kinoshita A; Tsuji E; Kiyose H; Taniguchi H; Noda K; Ideishi M; Inoue J; Tomita K; Arakawa K
Genetic analysis of the epithelial sodium channel in Liddle's syndrome.
Journal of hypertension 1998;16(8):1131-5.
-
1998: Ou J; Saku K; Jimi S; Ohta T; Zhang B; Pownall H J; Shimada Y; Tsujita Y; Arakawa K
Mechanism of action of probucol on cholesteryl ester transfer protein (CETP) mRNA in a Chinese hamster ovary cell line that had been stably transfected with a human CETP gene.
Biochimica et biophysica acta 1998;1393(1):153-60.
-
1998: Koga M; Sasaguri M; Miura S; Tashiro E; Kinoshita A; Ideishi M; Arakawa K
Plasma renin activity could be a useful predictor of left ventricular hypertrophy in essential hypertensives.
Journal of human hypertension 1998;12(7):455-61.
-
1998: So T; Nakashima Y; Imamura M; Arakawa K
Effects of local inhibition of the cardiac renin-angiotensin system with CV-11974 in a canine ischaemia-reperfusion model.
Clinical and experimental pharmacology & physiology 1998;25(7-8):503-9.
-
1998: Sakai T; Ideishi M; Miura S; Maeda H; Tashiro E; Koga M; Kinoshita A; Sasaguri M; Tanaka H; Shindo M; Arakawa K
Mild exercise activates renal dopamine system in mild hypertensives.
Journal of human hypertension 1998;12(6):355-62.
-
1998: Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S
A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia.
Clinical therapeutics 1998;20(3):539-48.
-
1998: Saku K; Takeda Y; Jimi S; Okabe M; Shirai K; Nii T; Naito S; Arakawa K
Long-term effect of low-density lipoprotein apheresis in a patient with heterozygous familial hypercholesterolemia: follow-up study using coronary angiography.
Journal of cardiology 1998;31(4):239-45.
-
1998: Huang W; Sasaki J; Matsunaga A; Nanimatsu H; Moriyama K; Han H; Kugi M; Koga T; Yamaguchi K; Arakawa K
A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(3):389-96.
-
1998: Matsuo K; Kumagai K; Annoura M; Ideishi M; Arakawa K
Mechanism of antiarrhythmic effects of class Ic drugs in paroxysmal atrial fibrillation in man.
Cardiology 1998;89(2):119-23.
-
1998: Nii T; Tsuchiya Y; Shirai K; Arakawa K
Electrocardiographic changes related to parasympathetic tone during right coronary angioplasty.
Cardiology 1998;89(1):29-32.
-
1997: Matsunaga A; Inoue T; Koga T; Mori K; Kugi M; Sasaki J; Arakawa K
Effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11(6):747-50.
-
1997: Saku K; Takeda Y; Nii T; Shirai K; Okabe M; Ohta T; Arakawa K
Three-dimensional spiral computed tomography angiography as an alternative imaging modality for a silent dissecting aortic aneurysm--a case report.
Angiology 1997;48(12):1067-71.
-
1997: Liu R; Saku K; Jimi S; Ohta T; Zhang B; Takebayashi S; Arakawa K
Mechanism of action of gemfibrozil on HDL metabolism and atherosclerosis in WHHL rabbits.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11(5):659-68.
-
1997: Saku K; Zhang B; Ohta T; Arakawa K
Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits.
American journal of hypertension 1997;10(9 Pt 1):1027-33.
-
1997: Saku K; Takeda Y; Shirai K; Nii T; Ohta T; Arakawa K
Long-term follow-up by coronary angiography in a patient with heterozygous familial hypercholesterolemia: a case report.
Journal of cardiology 1997;30(3):137-42.
-
1997: Uehara Y; Arakawa K
[Non pharmacological therapy in hypertensive patients--effect of physical exercise on hypertension]
Nippon rinsho. Japanese journal of clinical medicine 1997;55(8):2034-8.
-
1997: Nakayama S; Urata H; Arakawa K
[Pathophysiological roles of human chymase]
Nippon rinsho. Japanese journal of clinical medicine 1997;55(8):1903-8.
-
1997: Okabe M; Fukuda K; Arakawa K; Kikuchi M
Chronic variant of myocarditis associated with hepatitis C virus infection.
Circulation 1997;96(1):22-4.
-
1997: Sasaguri M; Maeda H; Noda K; Tsuji E; Kinoshita A; Ideishi M; Ogata S; Arakawa K
Purification and characterization of a kinin- and angiotensin II-forming enzyme in the dog heart.
Journal of hypertension 1997;15(6):675-82.
-
1997: Matsuo K; Kumagai K; Annoura M; Yamanouchi Y; Handa K; Nakashima Y; Hiroki T; Arakawa K
Effects of an angiotensin II antagonist on reperfusion arrhythmias in dogs.
Pacing and clinical electrophysiology : PACE 1997;20(4 Pt 1):938-45.
-
1997: Zhang B; Saku K; Arakawa K
Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.
Metabolism: clinical and experimental 1997;46(3):273-81.
-
1997: Naitoh M; Suzuki H; Arakawa K; Matsumoto A; Ichihara A; Matsuda H; Kubota E; Murakami M; Nakamoto H; Saruta T
Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension.
The American journal of physiology 1997;272(2 Pt 2):H679-87.
-
1997: Okabe M; Nomoto J; Fukuda K; Arakawa K; Kikuchi M
Right bundle block in a patient with acute posterior myocardial infarction.
Japanese circulation journal 1997;61(1):78-81.
-
1996: Arakawa K
Serine protease angiotensin II systems.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1996;14(5):S3-7.
-
1996: Bai H; Saku K; Liu R; Oribe Y; Yamamoto K; Arakawa K
Polymorphism of the apolipoprotein A-IV gene and its significance in lipid metabolism and coronary heart disease in a Japanese population.
European journal of clinical investigation 1996;26(12):1115-24.
-
1996: Moriyama K; Sasaki J; Takada Y; Matsunaga A; Fukui J; Albers J J; Arakawa K
A cysteine-containing truncated apo A-I variant associated with HDL deficiency.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(12):1416-23.
-
1996: Tsuji E; Tsuji Y; Misumi Y; Fujita A; Sasaguri M; Ideishi M; Arakawa K
Molecular cloning of a novel rat salt-tolerant protein by functional complementation in yeast.
Biochemical and biophysical research communications 1996;229(1):134-8.
-
1996: Bai H; Saku K; Liu R; Jimi S; Arakawa K
Analysis of a new polymorphism in the human apolipoprotein A-I gene: association with serum lipoprotein levels and coronary heart disease.
Journal of cardiology 1996;28(4):207-12.
-
1996: Koga M; Ideishi M; Miura S; Sakai T; Tashiro E; Kinoshita A; Sasaguri M; Tanaka H; Shindo M; Arakawa K
Role of endogenous ouabain-like substance during graded exercise in hypertensive individuals.
Journal of human hypertension 1996;10(7):477-81.
-
1996: Kawaguchi H; Mori T; Kawano T; Kono S; Sasaki J; Arakawa K
Band neutrophil count and the presence and severity of coronary atherosclerosis.
American heart journal 1996;132(1 Pt 1):9-12.
-
1996: Arakawa K
Effect of exercise on hypertension and associated complications.
Hypertension research : official journal of the Japanese Society of Hypertension 1996;19 Suppl 1():S87-91.
-
1996: Handa K; Takao M; Nomoto J; Oku K; Shirai K; Saku K; Arakawa K
Evaluation of the coagulation and fibrinolytic systems in men with intermittent claudication.
Angiology 1996;47(6):543-8.
-
1996: Moriyama K; Sasaki J; Takada Y; Arakawa F; Matsunaga A; Ito Y; Arakawa K
Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis.
Biochimica et biophysica acta 1996;1301(3):185-90.
-
1996: Arakawa K; Suzuki H; Naitoh M; Matsumoto A; Hayashi K; Matsuda H; Ichihara A; Kubota E; Saruta T
Role of adenosine in the renal responses to contrast medium.
Kidney international 1996;49(5):1199-206.
-
1996: Saku K; Zhang B; Okamoto T; Takeda Y; Liu K; Jimi S; Arakawa K
Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
Journal of human hypertension 1996;10(4):263-8.
-
1996: Moriyama K; Sasaki J; Matsunaga A; Takada Y; Kagimoto M; Arakawa K
Identification of two apolipoprotein variants, A-I Karatsu (Tyr 100-->His) and A-I Kurume (His 162-->Gln).
Clinical genetics 1996;49(2):79-84.
-
1996: Moriyama K; Sasaki J; Matsunaga A; Arakawa K
Identification of two apolipoprotein variants, A-I Kaho (Asp 51-->Val) and A-I Lys 107 deletion.
Journal of atherosclerosis and thrombosis 1996;3(1):12-6.
-
1996: Kimoto K; Inoue T; Oku K; Mori T; Kusuda M; Handa K; Sakata N; Sasaki J; Arakawa K
Relation of C4b-binding protein to athero-sclerosis of the descending thoracic aorta.
Artery 1996;22(2):101-14.
-
1996: Saku K; Okamoto T; Takeda Y; Jimi S; Zhang B; Bai H; Liu R; Arakawa K
Short-term effects of a high-sucrose diet on plasma lipid, lipoprotein cholesterol, tissue lipoprotein lipase and hepatic triglyceride lipase in rats.
Artery 1996;22(1):36-48.
-
1995: Saku K; Jimi S; Sasaki N; Nii T; Shirai K; Koga N; Arakawa K
Reduced coronary vasodilation in patients with familial hypercholesterolemia following intracoronary injection of isosorbide dinitrate.
Japanese circulation journal 1995;59(12):808-14.
-
1995: Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
Diabetologia 1995;38(12):1434-42.
-
1995: Imamura M; Tsuchiya Y; Tahara H; Nii T; Nakashima Y; Arakawa K; Kawaguchi H
Acute myocardial infarction in a patient with primary coronary dissection and severe coronary vasospasm. A case report.
Angiology 1995;46(10):951-5.
-
1995: Matsunaga A; Sasaki J; Moriyama K; Arakawa F; Takada Y; Nishi K; Hidaka K; Arakawa K
Population frequency of apolipoprotein E5 (Glu3-->Lys) and E7 (Glu244-->Lys, Glu245-->Lys) variants in western Japan.
Clinical genetics 1995;48(2):93-9.
-
1995: Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
International journal of clinical pharmacology and therapeutics 1995;33(7):420-6.
-
1995: Arakawa K; Miura S; Koga M; Kinoshita A; Urata H; Kiyonaga A
Activation of renal dopamine system by physical exercise.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18 Suppl 1():S73-7.
-
1995: Sakai T; Maeda H; Matsumoto N; Miura S; Kinoshita A; Sasaguri M; Ideishi M; Tanaka H; Shindo M; Arakawa K
Plasma free and sulfoconjugated dopamine before and after a half-marathon.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18 Suppl 1():S161-3.
-
1995: Sasaki J; Kajiyama G; Kusukawa R; Shichiri M; Sunaga T; Mashiba H; Tanaka N; Nonaka K; Arakawa K
Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension.
International journal of clinical pharmacology and therapeutics 1995;33(6):366-70.
-
1995: Saku K; Liu R; Jimi S; Matsuo K; Yamamoto K; Yanagita T; Arakawa K
Combined effects of pravastatin and probucol on high-density lipoprotein apolipoprotein A-I kinetics in cholesterol-fed rabbits.
Japanese circulation journal 1995;59(5):292-8.
-
1995: Moroe K; Kimoto K; Inoue T; Annoura M; Oku K; Arakawa K; Hiroki T; Kiyonaga A; Mukaino Y; Shindo M
Evaluation of abnormal signal-averaged electrocardiograms in young athletes.
Japanese circulation journal 1995;59(5):247-56.
-
1995: Kono K; Arakawa K
Methicillin-resistant Staphylococcus aureus (MRSA) isolated in clinics and hospitals in the Fukuoka city area.
The Journal of hospital infection 1995;29(4):265-73.
-
1995: Sasaguri M; Ideishi M; Ogata S; Miura S; Ikeda M; Arakawa K
Human urinary kallikrein can generate angiotensin II from homologous renin substrates.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18(1):33-7.
-
1995: Mori T; Sasaki J; Kawaguchi H; Handa K; Takada Y; Matsunaga A; Kono S; Arakawa K
Serum glycoproteins and severity of coronary atherosclerosis.
American heart journal 1995;129(2):234-8.
-
1995: Bai H; Saku K; Liu R; Imamura M; Arakawa K
Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population.
Human genetics 1995;95(1):102-4.
-
1995: Gondo N; Kumagai K; Matsuo K; Ogawa M; Annoura M; Moroe K; Arakawa K
The best criterion for discrimination between patients with and without paroxysmal atrial fibrillation on signal-averaged electrocardiogram.
The American journal of cardiology 1995;75(1):93-5.
-
1995: Okabe M; Fukuda K; Nakashima Y; Arakawa K; Kikuchi M
An isolated left ventricular lesion associated with left ventricular tachycardia--arrhythmogenic "left" ventricular dysplasia?
Japanese circulation journal 1995;59(1):49-54.
-
1995: Motoyama M; Sunami Y; Kinoshita F; Irie T; Sasaki J; Arakawa K; Kiyonaga A; Tanaka H; Shindo M
The effects of long-term low intensity aerobic training and detraining on serum lipid and lipoprotein concentrations in elderly men and women.
European journal of applied physiology and occupational physiology 1995;70(2):126-31.
-
1995: Abe K K; Michinaga I; Hiratsuka T; Ogahara S; Naito S; Arakawa K; Tsuru N; Tokieda K
Association of DQB1*0302 alloantigens in Japanese pediatric patients with steroid-sensitive nephrotic syndrome.
Nephron 1995;70(1):28-34.
-
1995: Saku K; Zhang B; Jimi S; Bai H; Hirata K; Sasaki N; Liu R; Arakawa K
High-density lipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probucol and bezafibrate.
European journal of clinical pharmacology 1995;48(3-4):209-15.
-
1995: Inoue T; Oku K; Kimoto K; Takao M; Nomoto J; Handa K; Kono S; Arakawa K
Relationship of cigarette smoking to the severity of coronary and thoracic aortic atherosclerosis.
Cardiology 1995;86(5):374-9.
-
1994: Handa K; Kono S; Ishii H; Shinchi K; Imanishi K; Arakawa K
Relationship of alcohol consumption and smoking to plasma cortisol and blood pressure.
Journal of human hypertension 1994;8(12):891-4.
-
1994: Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
International journal of clinical pharmacology and therapeutics 1994;32(12):660-4.
-
1994: Saku K; Jimi S; Ohta T; Arakawa K
[Tangier disease]
Nippon rinsho. Japanese journal of clinical medicine 1994;52(12):3236-40.
-
1994: Naitoh M; Suzuki H; Murakami M; Matsumoto A; Arakawa K; Ichihara A; Nakamoto H; Oka K; Yamamura Y; Saruta T
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
The American journal of physiology 1994;267(6 Pt 2):H2245-54.
-
1994: Araki K; Sasaki J; Matsunaga A; Takada Y; Moriyama K; Hidaka K; Arakawa K
Characterization of two new human apolipoprotein A-I variants: apolipoprotein A-I Tsushima (Trp-108-->Arg) and A-I Hita (Ala-95-->Asp).
Biochimica et biophysica acta 1994;1214(3):272-8.
-
1994: Nii T; Arakawa K
Increased left ventricular non-uniformity in hypertensive patients with angina.
Coronary artery disease 1994;5(10):809-13.
-
1994: Miura S; Ideishi M; Sakai T; Motoyama M; Kinoshita A; Sasaguri M; Tanaka H; Shindo M; Arakawa K
Angiotensin II formation by an alternative pathway during exercise in humans.
Journal of hypertension 1994;12(10):1177-81.
-
1994: Sasaki J; Ogihara T; Yokoyama M; Kajiyama G; Mashiba H; Sunaga T; Nonaka K; Shichiri M; Tanaka N; Arakawa K
Comparative effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic-blocking activity, and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertension.
American journal of hypertension 1994;7(10 Pt 2):161S-166S.
-
1994: Ideishi M; Miura S; Sakai T; Sasaguri M; Misumi Y; Arakawa K
Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
Journal of hypertension 1994;12(6):653-61.
-
1994: Saku K; Liu R; Ohta T; Jimi S; Matsuda I; Arakawa K
Plasma HDL levels are regulated by the catabolic rate of large particles of lipoprotein containing apo-A-I.
Biochemical and biophysical research communications 1994;200(1):557-61.
-
1994: Zhang B; Saku K; Hirata K; Liu R; Tateishi K; Shiomi M; Arakawa K
Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril.
Metabolism: clinical and experimental 1994;43(3):360-6.
-
1994: Nii T; Tsuchiya Y; Tahara H; Imamura M; Nakashima Y; Arakawa K
Coronary collateral circulation and diastolic function.
International journal of cardiology 1994;44(1):37-44.
-
1994: Saku K; Bai H; Hirata K; Liu R; Zhang B; Ohkubo K; Yamamoto K; Arakawa K
In vitro conversion of recombinant human proapolipoprotein A-I to apolipoprotein A-I.
Biochimica et biophysica acta 1994;1217(1):29-30.
-
1994: Gondo N; Kumagai K; Matsuo K; Annoura M; Moroe K; Arakawa K
Electrophysiological properties in paroxysmal atrial fibrillation complicated with the Wolff-Parkinson-White syndrome: comparison with paroxysmal atrial fibrillation alone.
Cardiology 1994;84(4-5):292-7.
-
1994: Kumagai K; Gondo N; Matsuo K; Annoura M; Moroe K; Nakashima Y; Hiroki T; Arakawa K
Wavelength index: a predictor of the response to disopyramide in paroxysmal lone atrial fibrillation.
Cardiology 1994;85(3-4):184-92.
-
1994: Ideishi M; Miura S; Sakai T; Maeda H; Kinoshita A; Sasaguri M; Jimi S; Arakawa K
Comparative effects of an angiotensin-converting enzyme inhibitor and an angiotensin II antagonist in Dahl rats.
Blood pressure. Supplement 1994;5():99-104.
-
1994: Matsunaga A; Sasaki J; Hidaka K; Takada Y; Araki K; Moriyama K; Arakawa K
Pravastatin-induced changes in receptor-mediated metabolism of low density lipoprotein in guinea pigs.
Artery 1994;21(2):94-113.
-
1993: Handa K; Kimoto K; Kawaguchi H; Mori T; Matsunaga A; Sasaki J; Arakawa K
Plasmin and thrombin inhibitors in essentially untreated patients with coronary artery spasm.
International journal of cardiology 1993;42(3):263-7.
-
1993: Tashiro E; Miura S; Koga M; Sasaguri M; Ideishi M; Ikeda M; Tanaka H; Shindo M; Arakawa K
Crossover comparison between the depressor effects of low and high work-rate exercise in mild hypertension.
Clinical and experimental pharmacology & physiology 1993;20(11):689-96.
-
1993: Hirata K; Kikuchi S; Saku K; Jimi S; Zhang B; Naito S; Hamaguchi H; Arakawa K
Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus.
Kidney international 1993;44(5):1062-70.
-
1993: Nakashima Y; Nii T; Ikeda M; Arakawa K
Role of left ventricular regional nonuniformity in hypertensive diastolic dysfunction.
Journal of the American College of Cardiology 1993;22(3):790-5.
-
1993: Liu R; Saku K; Kostner G M; Hirata K; Zhang B; Shiomi M; Arakawa K
In vivo kinetics of lipoprotein(a) in homozygous Watanabe heritable hyperlipidaemic rabbits.
European journal of clinical investigation 1993;23(9):561-5.
-
1993: Bai H; Saku K; Liu R; Funke H; von Eckardstein A; Arakawa K
Polymorphic site study at codon 347 of apolipoprotein A-IV in a Japanese population.
Biochimica et biophysica acta 1993;1174(3):279-81.
-
1993: Urabe Y; Ideishi M; Sasaguri M; Ikeda M; Arakawa K
Beneficial effects of a serine protease inhibitor in peripheral vascular disease.
The American journal of cardiology 1993;72(2):218-22.
-
1993: Saku K; Mukaino Y; Ying H; Arakawa K
Characteristics of reactive electropermeable points on the auricles of coronary heart disease patients.
Clinical cardiology 1993;16(5):415-9.
-
1993: Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K
Proarrhythmic effects of class Ic drugs.
Clinical therapeutics 1993;15(3):559-66.
-
1993: Saku K; Liu R; Ohkubo K; Bai H; Hirata K; Yamamoto K; Morimoto Y; Yamada K; Arakawa K
In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits.
Biochimica et biophysica acta 1993;1167(3):257-63.
-
1993: Miura S; Matauoka H; Tashiro E; Sasaguri M; Ideishi M; Ikeda M; Arakawa K
[A case of idiopathic hyperaldosteronism diagnosed by adrenal imaging]
Fukuoka igaku zasshi = Hukuoka acta medica 1993;84(3):100-2.
-
1993: Okabe M; Fukuda K; Nakashima Y; Hiroki T; Arakawa K; Kikuchi M
Pathological extent of interventricular septal infarction in patients with acute anteroseptal myocardial infarction with and without right bundle branch block.
Japanese heart journal 1993;34(2):121-9.
-
1993: Noda K; Sasaguri M; Ideishi M; Ikeda M; Arakawa K
Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs.
Cardiovascular research 1993;27(2):334-40.
-
1993: Matsunaga A; Araki K; Moriyama K; Handa K; Arakawa F; Nishi K; Sasaki J; Arakawa K
Detection of a point mutation in cholesteryl ester transfer protein gene by polymerase chain reaction-mediated site-directed mutagenesis.
Biochimica et biophysica acta 1993;1166(1):131-4.
-
1993: Shirai K; Nii T; Imamura M; Kawano T; Mori T; Nakashima Y; Sasaki J; Arakawa K
Low serum apolipoprotein A-I level in patients with vasospastic angina.
American heart journal 1993;125(2 Pt 1):320-3.
-
1993: Kumagai K; Matsuo K; Ono M; Yamanouchi Y; Moroe K; Hamasaki N; Arakawa K
Effects of verapamil on electrophysiological properties in paroxysmal atrial fibrillation.
Pacing and clinical electrophysiology : PACE 1993;16(2):309-16.
-
1993: Ideishi M; Noda K; Sasaguri M; Ikeda M; Arakawa K
Angiotensin II forming activity of vascular endothelial and smooth muscle cells.
Artery 1993;20(2):95-102.
-
1993: Sasaki N; Saku K; Moroe K; Zhang B; Hirata K; Liu R; Arakawa K
Long-term administration of probucol and QTc interval prolongation.
Artery 1993;20(2):115-21.
-
1993: Okura Y; Saku K; Hirata K; Zhang B; Liu R; Ogahara S; Naito S; Kajiyama G; Arakawa K
Serum lipoprotein (a) levels in maintenance hemodialysis patients.
Nephron 1993;65(1):46-50.
-
1993: Saku K; Zhang B; Hirata K; Okura Y; Bai H; Liu R; Arakawa K
Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.
European journal of clinical pharmacology 1993;44(6):535-9.
-
1993: Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K; Hiroki T
Use of monophasic action potentials to evaluate postpacing T wave changes.
Cardiology 1993;83(4):244-9.
-
1992: Saku K; Zhang B; Hirata K; Liu R; Sasaki N; Sakai T; Ying H; Arakawa K
Effects of manidipine and delapril on serum lipids, lipoproteins, and apolipoproteins in patients with mild to moderate essential hypertension: a randomized trial with one-year follow-up.
Clinical therapeutics 1992;14(6):813-20.
-
1992: Saku K; Hirata K; Zhang B; Liu R; Ying H; Okura Y; Yoshinaga K; Arakawa K
Effects of Chinese herbal drugs on serum lipids, lipoproteins and apolipoproteins in mild to moderate essential hypertensive patients.
Journal of human hypertension 1992;6(5):393-5.
-
1992: Sasaki J; Saeki Y; Kawasaki K; Umeno M; Ikeda K; Handa K; Arakawa K
A multicenter comparison of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1992;6(5):471-4.
-
1992: Tashiro N; Kumagai K; Yamanouchi Y; Matsuo K; Hiroki T; Arakawa K
A fast Fourier transform analysis of coronary reperfusion-induced ventricular fibrillation and the modification by dibutyryl cyclic AMP in a cat model.
Clinical cardiology 1992;15(10):733-8.
-
1992: Moriyama K; Sasaki J; Matsunaga A; Arakawa F; Takada Y; Araki K; Kaneko S; Arakawa K
Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.
Biochimica et biophysica acta 1992;1128(1):58-64.
-
1992: Mori T; Handa K; Terao Y; Tanaka H; Kiyonaga A; Shindo M; Matsunaga A; Sasaki J; Arakawa K
Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1992;6(4):387-90.
-
1992: Matsusaki M; Ikeda M; Tashiro E; Koga M; Miura S; Ideishi M; Tanaka H; Shindo M; Arakawa K
Influence of workload on the antihypertensive effect of exercise.
Clinical and experimental pharmacology & physiology 1992;19(7):471-9.
-
1992: Nakashima Y; Nii T; Tashiro E; Ikeda M; Arakawa K
Cardiac effects of local angiotensin-converting enzyme inhibition in hypertensive patients.
Clinical and experimental pharmacology & physiology 1992;19(6):425-31.
-
1992: Handa K; Terao Y; Mori T; Tanaka H; Kiyonaga A; Matsunaga A; Sasaki J; Shindo M; Arakawa K
Different coagulability and fibrinolytic activity during exercise depending on exercise intensities.
Thrombosis research 1992;66(5):613-6.
-
1992: Matsunaga A; Handa K; Mori T; Moriyama K; Hidaka K; Yuki M; Sasaki J; Arakawa K
Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia.
Atherosclerosis 1992;94(2-3):241-8.
-
1992: Miura S; Arakawa K
[Indication of antihypertensive drugs]
Nippon rinsho. Japanese journal of clinical medicine 1992;50 Suppl():3-7.
-
1992: Koga M; Arakawa K
[An outline of exercise therapy in essential hypertensives]
Nippon rinsho. Japanese journal of clinical medicine 1992;50 Suppl():155-9.
-
1992: Kono K; Shiba K; Onuki K; Tohara S; Takeda S; Arakawa K; Nakashima H; Okuno T
[Methicillin-resistant Staphylococcus aureus (MRSA) isolated in hospitals in Fukuoka City area]
Nippon rinsho. Japanese journal of clinical medicine 1992;50(5):970-4.
-
1992: Miura S; Sasaguri M; Arakawa K
[Renin angiotensin system as a regulator of blood pressure--pharmacological actions and its mechanisms]
Nippon rinsho. Japanese journal of clinical medicine 1992;50 Suppl():77-83.
-
1992: Yamanouchi Y; Kumagai K; Tashiro N; Hiroki T; Arakawa K
Transesophageal low-energy synchronous cardioversion of atrial flutter/fibrillation in the dog.
American heart journal 1992;123(2):417-20.
-
1992: Handa K; Mori T; Tanaka H; Takada Y; Matsunaga A; Kiyonaga A; Shindo M; Sasaki J; Arakawa K
Administration of slow-release nifedipine does not affect lactate threshold, hormone release during exercise, and quality of life in normal subjects.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1992;6(1):85-90.
-
1992: Koga M; Ideishi M; Matsusaki M; Tashiro E; Kinoshita A; Ikeda M; Tanaka H; Shindo M; Arakawa K
Mild exercise decreases plasma endogenous digitalislike substance in hypertensive individuals.
Hypertension 1992;19(2 Suppl):II231-6.
-
1992: Okabe M; Fukuda K; Nakashima Y; Hiroki T; Arakawa K; Kikuchi M
Lymphocytic active myocarditis characterized by numerous clusters of lymphocytes: a chronic variant of myocarditis?
American heart journal 1992;123(1):128-36.
-
1992: Ogahara S; Naito S; Abe K; Michinaga I; Arakawa K
Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis.
Kidney international 1992;41(1):175-82.
-
1992: Hidaka K; Takada Y; Matsunaga A; Sasaki J; Arakawa K
Effects of probucol on low-density lipoprotein catabolism in guinea pigs.
Artery 1992;19(3):162-76.
-
1992: Noda K; Sasaguri M; Ideishi M; Ikeda M; Arakawa K
Cardioprotection of ACE inhibitor in ischemic heart is not dependent on the local angiotensin II formation.
Agents and actions. Supplements 1992;38 ( Pt 3)():217-27.
-
1992: Ikeda M; Matsusaki M; Kinoshita A; Koga M; Ideishi M; Sasaguri M; Tanaka H; Shindo M; Arakawa K
Active and inactive renin after exercise.
European journal of applied physiology and occupational physiology 1992;65(4):331-4.
-
1992: Matsunaga A; Hidaka K; Sasaki J; Arakawa K
Bunazosin enhances receptor-mediated endocytosis of low-density lipoproteins.
Artery 1992;19(6):307-17.
-
1992: Nii T; Nakashima Y; Kawano T; Arakawa K
Reduced left ventricular diastolic asynchrony after captopril in single vessel coronary artery disease.
Cardiology 1992;81(2-3):115-20.
-
1991: Matsumae T; Arakawa K; Naito S
[Plasmapheresis with membrane type plasma separator]
Nippon rinsho. Japanese journal of clinical medicine 1991;49 Suppl():560-6.
-
1991: Zhang B; Saku K; Hirata K; Liu R; Tateishi K; Yamamoto K; Arakawa K
Insulin resistance observed in WHHL rabbits.
Atherosclerosis 1991;91(3):277-8.
-
1991: Handa K; Sasaki J; Tanaka H; Kiyonaga A; Matsunaga A; Shindo M; Arakawa K
Effects of captopril on opioid peptides during exercise and quality of life in normal subjects.
American heart journal 1991;122(5):1389-94.
-
1991: Kumagai K; Yamanouchi Y; Hiroki T; Arakawa K
Effects of transcatheter cardioversion on chronic lone atrial fibrillation.
Pacing and clinical electrophysiology : PACE 1991;14(11 Pt 1):1571-5.
-
1991: Arakawa K
[Angiotensin converting enzyme inhibitor]
Nippon rinsho. Japanese journal of clinical medicine 1991;49(9):1978-83.
-
1991: Matsunaga A; Sasaki J; Takada Y; Hidaka K; Arakawa K
Effect of simvastatin on receptor mediated metabolism of low density lipoprotein in guinea pigs.
Atherosclerosis 1991;90(1):31-7.
-
1991: Kumagai K; Tashiro E; Moroe K; Hiroki T; Arakawa K
Effects of atrioventricular block on ventricular fibrillation threshold in dog.
Clinical cardiology 1991;14(7):583-6.
-
1991: Okabe M; Fukuda K; Nakashima Y; Hiroki T; Arakawa K; Kikuchi M
A quantitative histopathological study of right bundle branch block complicating acute anteroseptal myocardial infarction.
British heart journal 1991;65(6):317-21.
-
1991: Kusada-Funakoshi M; Sasaki J; Takada Y; Soji T; Arakawa K
Evidence that C4b-binding protein (proline-rich protein) is synthesized by hepatocytes.
Biochemical medicine and metabolic biology 1991;45(3):350-4.
-
1991: Kumagai K; Yamanouchi Y; Matsuo K; Tashiro N; Hiroki T; Arakawa K
Antiarrhythmic and proarrhythmic properties of diazepam demonstrated by electrophysiological study in humans.
Clinical cardiology 1991;14(5):397-401.
-
1991: Nii T; Nakashima Y; Nomoto J; Hiroki T; Ohshima F; Arakawa K
Normalization of reverse redistribution of thallium-201 with procainamide pretreatment in Wolff-Parkinson-White syndrome.
Clinical cardiology 1991;14(3):269-72.
-
1991: Saku K; Yoshinaga K; Okura Y; Ying H; Harada R; Arakawa K
Effects of polydextrose on serum lipids, lipoproteins, and apolipoproteins in healthy subjects.
Clinical therapeutics 1991;13(2):254-8.
-
1991: Kumagai K; Tashiro E; Tashiro N; Moroe K; Hiroki T; Arakawa K
Effects of dibutyryl cyclic AMP on ventricular vulnerability during atrioventricular block in dog.
Clinical cardiology 1991;14(1):62-4.
-
1991: Ikeda M; Oda K; Tsuji E; Noda K; Sasaguri M; Ideishi M; Arakawa K
Human renin activation by protease from the renin granule fraction of the dog kidney cortex.
Life sciences 1991;48(1):9-17.
-
1991: Nii T; Nakashima Y; Ikeda M; Arakawa K
Diastolic filling abnormality modified by left ventricular asynchrony in essential hypertension.
Acta cardiologica 1991;46(4):471-7.
-
1991: Ying H; Saku K; Ando K; Okura Y; Yoshinaga K; Harada R; Hidaka K; Arakawa K
Effects of Chinese herbal drug, dai-saiko-to on plasma lipids, lipoproteins and liver lipid contents in guinea pig.
Artery 1991;18(4):184-96.
-
1991: Kinoshita A; Koga M; Matsusaki M; Ikeda M; Tanaka H; Shindo M; Arakawa K
Changes of dopamine and atrial natriuretic factor by mild exercise for hypertensives.
Clinical and experimental hypertension. Part A, Theory and practice 1991;13(6-7):1275-90.
-
1990: Ying H; Saku K; Harada R; Takami N; Sasaki N; Saito Y; Arakawa K
Putative mechanisms of action of probucol on high-density lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits.
Biochimica et biophysica acta 1990;1047(3):247-54.
-
1990: Kumagai K; Yamato H; Yamanouchi Y; Matsuo K; Tashiro N; Hiroki T; Arakawa K
Automatic junctional tachycardia in an adult.
Clinical cardiology 1990;13(11):813-6.
-
1990: Handa K; Tanaka H; Shindo M; Kono S; Sasaki J; Arakawa K
Relationship of cigarette smoking to blood pressure and serum lipids.
Atherosclerosis 1990;84(2-3):189-93.
-
1990: Kumagai K; Yamanouchi Y; Tashiro N; Hiroki T; Arakawa K
Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in the dog.
Journal of the American College of Cardiology 1990;16(2):497-501.
-
1990: Sasaki J; Arakawa K
Effects of short- and long-term administration of nifedipine on serum lipoprotein metabolism in patients with mild hypertension.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1990;4 Suppl 5():1033-5.
-
1990: Kitajima K; Sasaki J; Kono S; Arakawa K
Prognostic significance of daily physical activity after first acute myocardial infarction.
American heart journal 1990;119(5):1193-4.
-
1990: Sasaki J; Takada Y; Handa K; Kusuda M; Tanabe Y; Matsunaga A; Arakawa K
Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers.
Clinical therapeutics 1990;12(3):263-8.
-
1990: Takada Y; Sasaki J; Ogata S; Nakanishi T; Ikehara Y; Arakawa K
Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu----Lys). A novel apolipoprotein variant.
Biochimica et biophysica acta 1990;1043(2):169-76.
-
1990: Saku K; Ying H; Arakawa K
Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension.
Clinical therapeutics 1990;12(2):132-8.
-
1990: Handa K; Sasaki J; Saku K; Kono S; Arakawa K
Alcohol consumption, serum lipids and severity of angiographically determined coronary artery disease.
The American journal of cardiology 1990;65(5):287-9.
-
1990: Yoshida K; Sasaguri M; Kinoshita A; Ideishi M; Ikeda M; Arakawa K
A case of a clinically "silent" pheochromocytoma.
Japanese journal of medicine 1990;29(1):27-31.
-
1990: Saku K; Fujino M; Yamamoto K; Ying H; Tashiro N; Harada R; Okabe M; Arakawa K
Cardiac function of WHHL rabbit, an animal model of familial hypercholesterolemia.
Artery 1990;17(5):271-80.
-
1990: Sasaguri M; Ideishi M; Ikeda M; Arakawa K
Inhibitory effects of kinins on angiotensin I conversion in the local circulation.
Clinical and experimental hypertension. Part A, Theory and practice 1990;12(4):551-69.
-
1990: Ideishi M; Kishikawa K; Kinoshita A; Sasaguri M; Ikeda M; Takebayashi S; Arakawa K
High-renin malignant hypertension secondary to an aldosterone-producing adenoma.
Nephron 1990;54(3):259-63.
-
1990: Ideishi M; Sasaguri M; Ikeda M; Arakawa K
Angiotensin-converting activity of tissue kallikrein.
Nephron 1990;55 Suppl 1():62-4.
-
1990: Ideishi M; Sasaguri M; Ikeda M; Arakawa K
Substrate-dependent angiotensin II formation in the peripheral circulation.
Life sciences 1990;46(5):335-41.
-
1989: Arakawa K
Non-pharmacologic measures for lowering blood pressure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1989;3(6):847-52.
-
1989: Saku K; Yamamoto K; Sakai T; Yanagida T; Hidaka K; Sasaki J; Arakawa K
Kinetics of HDL-apo A-I in the WHHL rabbit, an animal model of familial hypercholesterolemia.
Atherosclerosis 1989;79(2-3):225-30.
-
1989: Nomoto J; Kuramitsu K; Kinoshita A; Saku K; Sasaki J; Arakawa K
A case of hypopituitarism and type V hyperlipidemia.
Japanese journal of medicine 1989;28(5):621-4.
-
1989: Sasaki J; Handa K; Arakawa K
Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
Clinical therapeutics 1989;11(5):580-3.
-
1989: Moroe K; Hiroki T; Okabe M; Sasaki Y; Fukuda K; Arakawa K
A transarterial approach of electrical ablation of atrioventricular junction in a dog model: comparison of the effects between high and low energy shocks.
Pacing and clinical electrophysiology : PACE 1989;12(9):1474-84.
-
1989: Sasaki J; Koga S; Uzawa H; Arakawa K
Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
International journal of clinical pharmacology, therapy, and toxicology 1989;27(8):402-7.
-
1989: Ideishi M; Sasaguri M; Ikeda M; Arakawa K
Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
Clinical therapeutics 1989;11(4):441-51.
-
1989: Handa K; Kono S; Saku K; Sasaki J; Kawano T; Sasaki Y; Hiroki T; Arakawa K
Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis.
Atherosclerosis 1989;77(2-3):209-13.
-
1989: Saku K; Sasaki J; Arakawa K
Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
Clinical therapeutics 1989;11(3):331-40.
-
1989: Saku K; Sasaki J; Arakawa K
Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Clinical therapeutics 1989;11(2):247-57.
-
1989: Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
Clinical therapeutics 1989;11(2):219-24.
-
1989: Hirata Y; Saku K; Sasaguri M; Higashi Y; Ikeda M; Arakawa K
Abdominal aortic aneurysm of unknown origin and renovascular hypertension in a 25 year old male.
Japanese heart journal 1989;30(2):257-62.
-
1989: Gondo M; Maruta H; Arakawa K
Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart.
Japanese heart journal 1989;30(2):219-29.
-
1989: Saku K; Sasaki J; Naito S; Arakawa K
Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis.
Nephron 1989;51(2):220-4.
-
1989: Saku K; Sasaki J; Arakawa K
Lack of effect of chlorpromazine and haloperidol on serum lipid levels and on atherogenesis in cholesterol fed rabbits.
Artery 1989;16(3):151-8.
-
1989: Arakawa K
Beneficial and adverse effects of angiotensin converting enzyme inhibitors.
Advances in experimental medicine and biology 1989;247A():63-71.
-
1989: Sasaki J; Arakawa K
Effect of captopril on high-density lipoprotein subfractions in patients with mild to moderate essential hypertension.
Clinical therapeutics 1989;11(1):129-34.
-
1989: Sasaguri M; Ikeda M; Ideishi M; Arakawa K
Isolation of [hydroxyproline3]Lysyl-bradykinin formed by kallikrein from human plasma protein.
Advances in experimental medicine and biology 1989;247A():539-44.
-
1989: Tanabe Y; Urata H; Kiyonaga A; Ikeda M; Tanaka H; Shindo M; Arakawa K
Changes in serum concentrations of taurine and other amino acids in clinical antihypertensive exercise therapy.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11(1):149-65.
-
1989: Sasaki J; Arakawa K
Effects of enalapril on serum lipoproteins in mild essential hypertension.
Clinical therapeutics 1989;11(1):38-42.
-
1988: Kinoshita A; Urata H; Tanabe Y; Ikeda M; Tanaka H; Shindo M; Arakawa K
What types of hypertensives respond better to mild exercise therapy?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S631-3.
-
1988: Sasaguri M; Ikeda M; Ideishi M; Arakawa K
Identification of [hydroxyproline3]-bradykinin released from human plasma and plasma protein Cohn's fraction IV-4 by trypsin.
Biochemical and biophysical research communications 1988;157(1):210-7.
-
1988: Funakoshi M; Sasaki J; Arakawa K
Proline-rich protein is a glycoprotein and an acute phase reactant.
Biochimica et biophysica acta 1988;963(1):98-108.
-
1988: Yano A; Sasaki J; Arakawa K
Combined apical hypertrophic cardiomyopathy and acute myocardial infarction with coronary stenosis.
International journal of cardiology 1988;21(1):74-6.
-
1988: Tanaka H; Kumagai S; Shindo M; Yoshida T; Mutaguchi T; Moriyama Y; Hiroki T; Arakawa K
Effect of nifedipine, dilazep, dinitrates and propranolol on blood lactate accumulation during intensive graded exercise testing in healthy young subjects.
Japanese heart journal 1988;29(5):617-30.
-
1988: Handa K; Sasaki Y; Kiyonaga A; Fujino M; Hiroki T; Arakawa K
Acute pulmonary thromboembolism treated successfully by balloon angioplasty--a case report.
Angiology 1988;39(8):775-8.
-
1988: Arakawa K
Nonpharmacological treatment of hypertension.
Seminars in nephrology 1988;8(2):169-75.
-
1988: Tanabe Y; Sasaki J; Urata H; Kiyonaga A; Tanaka H; Shindo M; Arakawa K
Effect of mild aerobic exercise on lipid and apolipoprotein levels in patients with essential hypertension.
Japanese heart journal 1988;29(2):199-206.
-
1988: Sasaki J; Tanabe Y; Tanaka H; Saku K; Shindo M; Arakawa K
Elevated levels of HDL2-cholesterol and apo A-I in national class Japanese male marathon runners.
Atherosclerosis 1988;70(1-2):175-7.
-
1988: Moroe K; Saku K; Tashiro N; Hiroki T; Arakawa K
"Torsades de pointes" and atrioventricular block.
Clinical cardiology 1988;11(1):9-13.
-
1988: Sasaguri M; Ikeda M; Ideishi M; Arakawa K
Identification of [hydroxyproline3]-lysyl-bradykinin released from human plasma protein by kallikrein.
Biochemical and biophysical research communications 1988;150(1):511-6.
-
1988: Ikeda M; Sasaguri M; Maruta H; Arakawa K
Formation of angiotensin II by tonin-inhibitor complex.
Hypertension 1988;11(1):63-70.
-
1988: Saku K; Sata T; Naito S; Fukushima K; Takebayashi S; Arakawa K
Apolipoproteins in human biopsied nephrotic kidneys.
International urology and nephrology 1988;20(4):429-38.
-
1987: Fukuda K; Arakawa K
Pathological substratum for clinical features of fatal myocarditis.
Japanese circulation journal 1987;51(12):1379-84.
-
1987: Ideishi M; Ikeda M; Arakawa K
Direct angiotensin II formation by rat submandibular gland kallikrein.
Journal of biochemistry 1987;102(4):859-68.
-
1987: Urata H; Sasaki J; Tanabe Y; Kiyonaga A; Yoshida T; Tanaka H; Shindo M; Arakawa K
Effect of mild aerobic exercise on serum lipids and apolipoproteins in patients with coronary artery disease.
Japanese heart journal 1987;28(1):27-34.
-
1987: Hayashi T; Fujino M; Shindo M; Hiroki T; Arakawa K
Echocardiographic and electrocardiographic measures in obese children after an exercise program.
International journal of obesity 1987;11(5):465-72.
Sign-in to see more